Improving access to FH Genetic Testing: GENinCode

30th August 2024

  The NHS, in its Long-Term Plan, set a goal to identify 25% of people with FH within five years...

Read more about this story

Posted in

A new focus of lipid-lowering therapy for secondary prevention vascular and diabetic foot patients in a pharmacist-led clinic.

5th April 2024

Approximately 25-28 % of UK CVD deaths are due to raised cholesterol; every 1.0 mmol/L in LDL-C is associated with...

Read more about this story

Posted in